In her debut blog, Sally Turner considers a recent study on cannabis use and clinical outcomes in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
[read the full story...]
Ian Hamilton summarises a recent study exploring whether psychotic-like experiences are related to the discontinuation of cannabis consumption in young adults.
[read the full story...]
Ian Hamilton summarises the recently published CIRCLE trial, which looks at the clinical and cost-effectiveness of contingency management for cannabis use in early psychosis.
[read the full story...]
Luke Sheridan-Reins explores a recent paper on the contribution of cannabis use to variation in the incidence of psychotic disorder across Europe.
[read the full story...]
Suzi Gage summarises a recent GWAS of lifetime cannabis use, which reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Interesting new evidence ahead of our Mental Health Question Time #MHQT event in London tomorrow.
[read the full story...]
Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.
[read the full story...]
James MacCabe appraises a recent study, which looks at the association of combined patterns of tobacco and cannabis use in adolescents who go on to experience psychotic symptoms.
[read the full story...]
Thomas Richardson looks at a recent prospective cohort study in the British Journal of Psychiatry on adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis.
[read the full story...]
Ian Hamilton and Suzi Gage explain why we know so little about the relationship between cannabis and severe mental illness in women.
[read the full story...]
Marcus Munafo considers the findings of a systematic review of meta-analyses of observational studies, which looks at risk factors and peripheral biomarkers for psychotic disorders on the schizophrenia spectrum.
[read the full story...]
